CCL19 Protein
-
- Target Alle CCL19 Proteine anzeigen
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
- Protein-Typ
- Recombinant
- Biologische Aktivität
- Active
-
Spezies
- Maus
-
Quelle
- Escherichia coli (E. coli)
- Sequenz
- GANDAEDCCL SVTQRPIPGN IVKAFRYLLN EDGCRVPAVV FTTLRGYQLC APPDQPWVDR IIRRLKKSSA KNKGNSTRRS PVS
- Produktmerkmale
-
Purified recombinant Mouse MIP3 beta protein
Expression System: E.coli
Bioactivity: Determined by its ability to chemoattract human mature dendritic cells using a concentration range of 10.0-100.0 ng/mL. - Reinheit
- > 98 % pure
- Endotoxin-Niveau
- < 0.1 ng per µg (1 EU/µg).
- Top Product
- Discover our top product CCL19 Protein
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Reconstitute in distilled water to 0.1-1.0 mg/mL.
- Buffer
- Supplied lyophilized with no additives.
- Konservierungsmittel
- Without preservative
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- RT/-20 °C
-
- Target
- CCL19 (Chemokine (C-C Motif) Ligand 19 (CCL19))
- Andere Bezeichnung
- MIP3 beta (CCL19 Produkte)
- Synonyme
- CKb11 Protein, ELC Protein, MIP-3b Protein, MIP3B Protein, SCYA19 Protein, CCL19 Protein, Scya19 Protein, exodus-3 Protein, C-C motif chemokine ligand 19 Protein, chemokine (C-C motif) ligand 19 Protein, CCL19 Protein, ccl19 Protein, Ccl19 Protein
- Hintergrund
-
MIP-3 beta is a CC chemokine that is expressed in the thymus, lymph nodes and in activated bone marrow stromal cells and signals through the CCR7 receptor. MIP-3 beta is a chemoattractant for T and B lymphocytes and myeloid progenitor cells. Human MIP-3 beta is active on Mouse cells.
Alternative Names: MIP beta-3, MIP beta-3 protein, ELC protein, Macrophage Inflammatory Protein-3 beta protein, MIP-3 beta protein, Exodus-3 protein, CCL19 protein, MIP beta 3 protein, MIP3 beta, MIP beta 3 - Molekulargewicht
- 9.2 kDa
- Pathways
- Positive Regulation of Immune Effector Process
-